| Application no. and date | 20821492.4 (espacenet) (Federated) (European Patent Register), 20201113 | | Patent/reg. no. and date | DK/EP 4058453, 20251224 | | Publication date | 20220921 | | Priority no. and date | US 201962935502 P, 20191114 | | EP pub. no. and date |
EP 4058453 20220921 | | Effective date | | | Applicant/owner | Amgen Inc., One Amgen Center Drive
Thousand Oaks, CA 91320-1799, US | | Applicant ref. no. | 2040320 | | Inventor | PARSONS, Andrew T., One Amgen Center Drive Law Dept
Patent Operations, MS 28-5-A
Thousand Oaks, California 91320-1799, US,
BEAVER, Matthew, One Amgen Center Drive Law Dept
Patent Operations, MS 28-5-A
Thousand Oaks, California 91320-1799, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | C07D 471/04 (2006.01) , C07F 5/02 (2006.01) , C07F 5/05 (2006.01) | | Title | FORBEDRET SYNTESE AF KRAS G12C-INHIBITORFORBINDELSE | | Int. application no. | US2020060421 | | Int. publication no. | WO2021097212 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
